Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 18
  • Journal CiteScore: 4.35
  • Journal Impact Factor: 3.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page


Elevated Serum MMP-9 and MMP/TIMP-1 Ratio in Patients with Migrainous Infarction and Hemiplegic Migraine

Satoru Ikemoto, Ryuki Matsuura, Shin-Ichiro Hamano, Atsuro Daida, Jun Kubota, Yuko Hirata and Reiko Koichihara

Introduction: We investigated serum matrix metalloprotease-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) levels in patients with acute phase hemiplegic migraine and migrainous infarction.

Background: Migraine is a common disorder that is characterized by episodic headaches. Hemiplegic migraine and migrainous infarction are rare migraine-related conditions with unknown pathophysiology.

Methods and Findings: We evaluated serum MMP-9, TIMP-1, and the MMP-9/TIMP-1 ratio in patients with migrainous infarction (patient 1), hemiplegic migraine (patient 2), cerebral infarction with other causes (group 3, n=4), and non-organic disease (group 4, n=5). Serum MMP-9 levels were significantly higher in patients 1 and 2 than in groups 3 and 4. The serum TIMP-1 level was significantly lower in patient 1 than in groups 3 and 4. MMP-9/TIMP-1 ratios were higher in patients 1 and 2 than in groups 3 and 4.

Conclusion: MMP-9 levels and the MMP/TIMP-1 ratio may aid in the diagnosis of migraine, and therefore may provide a clue to the etiology of cerebral infarction.